{
    "clinical_study": {
        "@rank": "90553", 
        "acronym": "NAHIM", 
        "arm_group": {
            "arm_group_label": "Patients with MNGIE", 
            "description": "Patients of all races of any gender who are at least 5 years of age with a defect in thymidine phosphorylase may participate in this natural history study."
        }, 
        "brief_summary": {
            "textblock": "This is a multi-center natural history study of MNGIE (Mitochondrial NeurogastroIntestinal\n      Encephalopathy).   Patients will be followed over time to assess clinical symptoms.  The\n      investigators hope to learn more about the disease of MNGIE as well as develop useful\n      measures of disease status  for use in future clinical trials.\n\n      Additional clinical centers will be listed as they become available."
        }, 
        "brief_title": "The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)", 
        "completion_date": {
            "#text": "June 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)", 
        "condition_browse": {
            "mesh_term": [
                "Brain Damage, Chronic", 
                "Delirium", 
                "Encephalitis", 
                "Hepatic Encephalopathy", 
                "Neurotoxicity Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators will examine a total of 20 patients at six month intervals for up to five\n      years.   The investigators will evaluate gastrointestinal function, lean body mass,\n      neuropathy, neuropsychological capability, quality of life, nutrition, motor function and\n      biochemical parameters."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Thymidine Phosphorylase (TP) defect:\n\n               1. homozygous or\n\n               2. compound heterozygous mutations in the TYMP gene, and/or\n\n               3. TP enzyme activity of <20% of normal.\n\n          2. Increased plasma Thd > 3 micromole/L\n\n          3. Increased plasma dUrd > 7.5 micromole/L\n\n          4. Age requirement of at least 5 years of age.\n\n        Exclusion Criteria:\n\n          1. Participation in an interventional (study medication or other experimental\n             intervention) study (within 1 month of participation in this study).\n\n          2. Unable to travel to site for research visits.\n\n          3. Unwillingness to sign informed consent form.\n\n          4. Substance abuser"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "5 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Male or female, At least 5 years of age, with Thymidine Phosphorylase defect"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694953", 
            "org_study_id": "AAAI5453", 
            "secondary_id": "1U54NS078059"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "MNGIE", 
            "Mitochondrial", 
            "Mitochondrial Neurogastrointestinal encephalopathy"
        ], 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "contact": {
                "email": "ke4@columbia.edu", 
                "last_name": "Kris Engelstad, MS", 
                "phone": "212-305-6834"
            }, 
            "facility": {
                "address": {
                    "city": "New York City", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10032"
                }, 
                "name": "Columbia University"
            }, 
            "investigator": {
                "last_name": "Michio Hirano, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Rare Disease Clinical Research Network Natural History Study of MNGIE", 
        "other_outcome": {
            "description": "A short assessment of cognitive function  will be performed.", 
            "measure": "Score on Mini Mental State Exam", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "overall_contact": {
            "email": "NAMDC@columbia.edu", 
            "last_name": "Johnston Grier, BS", 
            "phone": "12123423671"
        }, 
        "overall_contact_backup": {
            "email": "NAMDC@columbia.edu", 
            "last_name": "Kris Engelstad, MS", 
            "phone": "12123056834"
        }, 
        "overall_official": {
            "affiliation": "Columbia University", 
            "last_name": "Michio Hirano, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The timed water swallow test evaluates the time it takes to swallow a small cup of water", 
            "measure": "Timed Water Swallow", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "reference": {
            "PMID": "22215544", 
            "citation": "Mart\u00ed R, L\u00f3pez LC, Hirano M. Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity. Methods Mol Biol. 2012;837:121-33. doi: 10.1007/978-1-61779-504-6_8."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694953"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Columbia University", 
            "investigator_full_name": "Michio Hirano", 
            "investigator_title": "Professor of Neurology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "A general neurological exam will be performed to assess the degree of neuropathy.", 
            "measure": "Degree of Neuropathy", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "source": "Columbia University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Columbia University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}